{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:06:23Z","timestamp":1794330383581,"version":"4.9.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41433-022-02056-9","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T11:03:17Z","timestamp":1650020597000},"page":"203-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Optical coherence tomography as retinal imaging biomarker of neuroinflammation\/neurodegeneration in systemic disorders in adults and children"],"prefix":"10.1038","volume":"37","author":[{"given":"Stela","family":"Vujosevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Margarita","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4851-0918","authenticated-orcid":false,"given":"Louise","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-175X","authenticated-orcid":false,"given":"Alessia","family":"Nuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Limoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"2056_CR1","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13:3391\u20136.","journal-title":"Mol Med Rep."},{"key":"2056_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010;129:154\u201369.","journal-title":"Immunology"},{"key":"2056_CR3","first-page":"88","volume":"312","author":"S Bakhtadze","year":"2021","unstructured":"Bakhtadze S, Geladze N, Khachapuridze N. Inflammation in childhood epilepsy syndromes. Georgian Med N. 2021;312:88\u201392.","journal-title":"Georgian Med N."},{"key":"2056_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/RMR.0000000000000187","volume":"27","author":"SV Sudhakar","year":"2018","unstructured":"Sudhakar SV, Muthusamy K, Shroff M. Imaging of childhood inflammatory brain diseases. Top Magn Reson Imaging. 2018;27:409\u201331.","journal-title":"Top Magn Reson Imaging"},{"key":"2056_CR5","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WNO.0000000000000551","volume":"37","author":"M Borchert","year":"2017","unstructured":"Borchert M, Liu GT, Pineles S, Waldman AT. Pediatric optic neuritis: what is new. J Neuroophthalmol. 2017;37:S14\u2013s22.","journal-title":"J Neuroophthalmol"},{"key":"2056_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5:463\u20136.","journal-title":"Curr Opin HIV AIDS"},{"key":"2056_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ene.14613","volume":"28","author":"WC Zhou","year":"2021","unstructured":"Zhou WC, Tao JX, Li J. Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: A systematic review and meta-analysis. Eur J Neurol. 2021;28:763\u201374.","journal-title":"Eur J Neurol"},{"key":"2056_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1352458509104586","volume":"15","author":"EA Yeh","year":"2009","unstructured":"Yeh EA, Weinstock-Guttman B, Lincoff N, Reynolds J, Weinstock A, Madurai N, et al. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Mult Scler (Houndmills, Basingstoke, Engl). 2009;15:802\u201310.","journal-title":"Mult Scler (Houndmills, Basingstoke, Engl)"},{"key":"2056_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.msard.2013.10.008","volume":"3","author":"AT Waldman","year":"2013","unstructured":"Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, et al. Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis. Mult Scler Relat Disord. 2013;3:326\u201334.","journal-title":"Mult Scler Relat Disord"},{"key":"2056_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, et al. Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler (Houndmills, Basingstoke, Engl). 2015;21:678\u201388.","journal-title":"Mult Scler (Houndmills, Basingstoke, Engl)"},{"key":"2056_CR11","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/acn3.51349","volume":"8","author":"WJC van Ballegoij","year":"2021","unstructured":"van Ballegoij WJC, Huffnagel IC, van de Stadt SIW, Weinstein HC, Bennebroek CAM, Engelen M, et al. Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy. Ann Clin Transl Neurol. 2021;8:1064\u201372.","journal-title":"Ann Clin Transl Neurol"},{"key":"2056_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/eye.2013.201","volume":"27","author":"G Alvarez","year":"2013","unstructured":"Alvarez G, Rey A, Sanchez-Dalmau FB, Mu\u00f1oz E, R\u00edos J, Ad\u00e1n A. Optical coherence tomography findings in spinocerebellar ataxia-3. Eye (Lond, Engl). 2013;27:1376\u201381.","journal-title":"Eye (Lond, Engl)"},{"key":"2056_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/IAE.0000000000001735","volume":"38","author":"D Tran-Viet","year":"2017","unstructured":"Tran-Viet D, Wong BM, Mangalesh S, Maldonado R, Cotten CM, Toth CA. Hanheld spectral domain optical coherence tomography imaging through the undilated pupil in infants born preterm or with hipoxic injury or hydrocephalus. Retina. 2017;38:1588\u201394.","journal-title":"Retina"},{"key":"2056_CR14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00417-020-04996-y","volume":"259","author":"L Grego","year":"2021","unstructured":"Grego L, Pignatto S, Busolini E, Rassu N, Samassa F, Prosperi R, et al. Spectral-domain OCT changes in retina and optic nerve in children with hypoxic-ischaemic encephalopathy. Graefe\u2019s Arch Clin Exp Ophthalmol = Albrecht von Graefes Arch fur klinische und experimentelle Ophthalmologie. 2021;259:1343\u201355.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol = Albrecht von Graefes Arch fur klinische und experimentelle Ophthalmologie"},{"key":"2056_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21:195\u2013218.","journal-title":"Brain Res Brain Res Rev"},{"key":"2056_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12035-009-8077-9","volume":"40","author":"MA Lynch","year":"2009","unstructured":"Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol. 2009;40:139\u201356.","journal-title":"Mol Neurobiol"},{"key":"2056_CR17","doi-asserted-by":"publisher","first-page":"Bio68","DOI":"10.1167\/iovs.17-21769","volume":"58","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Sim\u00f3 R. Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach. Invest Ophthalmol Vis Sci. 2017;58:Bio68\u2013bio75.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR18","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2337\/db05-1635","volume":"55","author":"DA Antonetti","year":"2006","unstructured":"Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55:2401\u201311.","journal-title":"Diabetes"},{"key":"2056_CR19","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.15-16554","volume":"56","author":"S Vujosevic","year":"2015","unstructured":"Vujosevic S, Micera A, Bini S, Berton M, Esposito G, Midena E. Aqueous humor biomarkers of m\u00fcller cell activation in diabetic eyes. Investigative Ophthalmol Vis Sci. 2015;56:3913\u20138.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"2056_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/aos.13294","volume":"95","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Torresin T, Bini S, Convento E, Pilotto E, Parrozzani R, et al. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Acta Ophthalmol. 2017;95:464\u201371.","journal-title":"Acta Ophthalmol"},{"key":"2056_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387\u201394.","journal-title":"Nat Neurosci"},{"key":"2056_CR22","doi-asserted-by":"publisher","first-page":"905058","DOI":"10.1155\/2013\/905058","volume":"2013","author":"S Vujosevic","year":"2013","unstructured":"Vujosevic S, Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and M\u00fcller cells alterations. J Diabetes Res. 2013;2013:905058.","journal-title":"J Diabetes Res"},{"key":"2056_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0368-7","volume":"12","author":"Y Yu","year":"2015","unstructured":"Yu Y, Chen H, Su SB. Neuroinflammatory responses in diabetic retinopathy. J Neuroinflammation. 2015;12:141.","journal-title":"J Neuroinflammation"},{"key":"2056_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/IAE.0000000000001304","volume":"37","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Bini S, Torresin T, Berton M, Midena G, Parrozzani R, et al. Hyperreflective retinal spots in normal and diabetic eyes: b-scan and en face spectral domain optical coherence tomography evaluation. Retina 2017;37:1092\u2013103.","journal-title":"Retina"},{"key":"2056_CR25","doi-asserted-by":"publisher","first-page":"491835","DOI":"10.1155\/2013\/491835","volume":"2013","author":"S Vujosevic","year":"2013","unstructured":"Vujosevic S, Bini S, Midena G, Berton M, Pilotto E, Midena E. Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res. 2013;2013:491835.","journal-title":"J Diabetes Res"},{"key":"2056_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/IAE.0b013e318217ffc7","volume":"32","author":"K Ogino","year":"2012","unstructured":"Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M, et al. Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina. 2012;32:77\u201385.","journal-title":"Retina"},{"key":"2056_CR27","doi-asserted-by":"crossref","unstructured":"Coscas GCF, Vismara S, Zourdanic A, Li Calzi CI. Optical coherence tomography in age-related macular degeneration: OCT in AMD. Publishing S, editor 2009 1\u2013389 p.","DOI":"10.1007\/978-3-642-01467-3"},{"key":"2056_CR28","doi-asserted-by":"crossref","first-page":"BIO211","DOI":"10.1167\/iovs.16-19778","volume":"58","author":"CA Curcio","year":"2017","unstructured":"Curcio CA, Zanzottera EC, Ach T, Balaratnasingam C, Freund KB. Activated retinal pigment epithelium, an optical coherence tomography biomarker for progression in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2017;58:BIO211\u2013BIO26.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2056_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1097\/IAE.0000000000000912","volume":"36","author":"S Vujosevic","year":"2016","unstructured":"Vujosevic S, Berton M, Bini S, Casciano M, Cavarzeran F, Midena E. Hyperreflective retinal spots and visual function after anti-vascular endothelial growth factor treatment in center-involving diabetic macular edema. Retina. 2016;36:1298\u2013308.","journal-title":"Retina."},{"key":"2056_CR30","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.ophtha.2020.03.024","volume":"127","author":"E Pilotto","year":"2020","unstructured":"Pilotto E, Miante S, Torresin T, Puthenparampil M, Frizziero L, Federle L, et al. Hyperreflective foci in the retina of active relapse-onset multiple sclerosis. Ophthalmology. 2020;127:1774\u20136.","journal-title":"Ophthalmology"},{"key":"2056_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00592-019-01424-4","volume":"57","author":"S Vujosevic","year":"2020","unstructured":"Vujosevic S, Toma C, Villani E, Muraca A, Torti E, Florimbi G, et al. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids. Acta Diabetol. 2020;57:287\u201396.","journal-title":"Acta Diabetol"},{"key":"2056_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajo.2016.02.002","volume":"164","author":"KC Chen","year":"2016","unstructured":"Chen KC, Jung JJ, Curcio CA, Balaratnasingam C, Gallego-Pinazo R, Dolz-Marco R, et al. Intraretinal hyperreflective foci in acquired vitelliform lesions of the macula: clinical and histologic study. Am J Ophthalmol. 2016;164:89\u201398.","journal-title":"Am J Ophthalmol"},{"key":"2056_CR33","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.ophtha.2015.07.008","volume":"122","author":"CE Pang","year":"2015","unstructured":"Pang CE, Messinger JD, Zanzottera EC, Freund KB, Curcio CA. The onion sign in neovascular age-related macular degeneration represents cholesterol crystals. Ophthalmology. 2015;122:2316\u201326.","journal-title":"Ophthalmology."},{"key":"2056_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.62.10.34","volume":"62","author":"D Cao","year":"2021","unstructured":"Cao D, Leong B, Messinger JD, Kar D, Ach T, Yannuzzi LA, et al. Hyperreflective foci, optical coherence tomography progression indicators in age-related macular degeneration, include transdifferentiated retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2021;62:34.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1167\/iovs.17-23042","volume":"59","author":"H Lee","year":"2018","unstructured":"Lee H, Jang H, Choi YA, Kim HC, Chung H. Association between soluble CD14 in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with diabetic macular edema. Investigative Ophthalmol Vis Sci. 2018;59:715\u201321.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"2056_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.ophtha.2009.09.027","volume":"117","author":"GG De\u00e1k","year":"2010","unstructured":"De\u00e1k GG, Bolz M, Kriechbaum K, Prager S, Mylonas G, Scholda C, et al. Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology. 2010;117:773\u20139.","journal-title":"Ophthalmology"},{"key":"2056_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/IAE.0b013e3182a48917","volume":"34","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Shirasawa M, Otsuka H, Sonoda Y. Retinal morphologic changes and concentrations of cytokines in eyes with diabetic macular edema. Retina. 2014;34:741\u20138.","journal-title":"Retina"},{"key":"2056_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0039-6257(84)90229-7","volume":"28","author":"G Coscas","year":"1984","unstructured":"Coscas G, Gaudric A. Natural course of nonaphakic cystoid macular edema. Surv Ophthalmol. 1984;28:471\u201384.","journal-title":"Surv Ophthalmol"},{"key":"2056_CR39","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1167\/iovs.09-5041","volume":"51","author":"HW van Dijk","year":"2010","unstructured":"van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci. 2010;51:3660\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR40","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1167\/iovs.11-8997","volume":"53","author":"HW van Dijk","year":"2012","unstructured":"van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2012;53:2715\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR41","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1167\/iovs.10-6293","volume":"52","author":"AJ Barber","year":"2011","unstructured":"Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011;52:1156\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","volume":"139","author":"SK Lynch","year":"2017","unstructured":"Lynch SK, Abr\u00e0moff MD. Diabetic retinopathy is a neurodegenerative disorder. Vis Res. 2017;139:101\u20137.","journal-title":"Vis Res"},{"key":"2056_CR43","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/brain\/aww219","volume":"139","author":"B Knier","year":"2016","unstructured":"Knier B, Schmidt P, Aly L, Buck D, Berthele A, M\u00fchlau M, et al. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain. 2016;139:2855\u201363.","journal-title":"Brain."},{"key":"2056_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1756285616655264","volume":"9","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"Martinez-Lapiscina EH, Sepulveda M, Torres-Torres R, Alba-Arbalat S, Llufriu S, Blanco Y, et al. Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord. 2016;9:436\u201340.","journal-title":"Ther Adv Neurol Disord"},{"key":"2056_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1134-5","volume":"19","author":"S Zafar","year":"2019","unstructured":"Zafar S, Sachdeva M, Frankfort BJ, Channa R. Retinal neurodegeneration as an early manifestation of diabetic eye disease and potential neuroprotective therapies. Curr Diabetes Rep. 2019;19:17.","journal-title":"Curr Diabetes Rep."},{"key":"2056_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ajo.2010.01.039","volume":"150","author":"AS Maheshwary","year":"2010","unstructured":"Maheshwary AS, Oster SF, Yuson RM, Cheng L, Mojana F, Freeman WR. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol. 2010;150:63\u20137.","journal-title":"Am J Ophthalmol"},{"key":"2056_CR47","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000004500","volume":"89","author":"BJ Kim","year":"2017","unstructured":"Kim BJ, Irwin DJ, Song D, Daniel E, Leveque JD, Raquib AR, et al. Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration. Neurology. 2017;89:1604\u201311.","journal-title":"Neurology."},{"key":"2056_CR48","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","volume":"132","author":"JK Sun","year":"2014","unstructured":"Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132:1309\u201316.","journal-title":"JAMA Ophthalmol"},{"key":"2056_CR49","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1001\/jamaophthalmol.2015.0972","volume":"133","author":"SH Radwan","year":"2015","unstructured":"Radwan SH, Soliman AZ, Tokarev J, Zhang L, van Kuijk FJ, Koozekanani DD. Association of disorganization of retinal inner layers with vision after resolution of center-involved diabetic macular edema. JAMA Ophthalmol. 2015;133:820\u20135.","journal-title":"JAMA Ophthalmol"},{"key":"2056_CR50","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/ijms19040942","volume":"19","author":"A R\u00fcbsam","year":"2018","unstructured":"R\u00fcbsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci. 2018;19:942.","journal-title":"Int J Mol Sci"},{"key":"2056_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-021-00239-1","volume":"8","author":"S Nian","year":"2021","unstructured":"Nian S, Lo ACY, Mi Y, Ren K, Yang D. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis. 2021;8:15.","journal-title":"Eye Vis"},{"key":"2056_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","volume":"25","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2014;25:23\u201333.","journal-title":"Trends Endocrinol Metab"},{"key":"2056_CR53","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2337\/db16-1453","volume":"66","author":"AR Santos","year":"2017","unstructured":"Santos AR, Ribeiro L, Bandello F, Lattanzio R, Egan C, Frydkjaer-Olsen U, et al. Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR Project. Diabetes 2017;66:2503\u201310.","journal-title":"Diabetes"},{"key":"2056_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/iovs.62.3.35","volume":"62","author":"G Montesano","year":"2021","unstructured":"Montesano G, Ometto G, Higgins BE, Das R, Graham KW, Chakravarthy U, et al. Evidence for structural and functional damage of the inner retina in diabetes with no diabetic retinopathy. Investigative Ophthalmol Vis Sci. 2021;62:35.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"2056_CR55","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s10792-021-01864-4","volume":"41","author":"D Soni","year":"2021","unstructured":"Soni D, Sagar P, Takkar B. Diabetic retinal neurodegeneration as a form of diabetic retinopathy. Int Ophthalmol. 2021;41:3223\u201348.","journal-title":"Int Ophthalmol"},{"key":"2056_CR56","doi-asserted-by":"publisher","first-page":"e0231552","DOI":"10.1371\/journal.pone.0231552","volume":"15","author":"JA van de Kreeke","year":"2020","unstructured":"van de Kreeke JA, Darma S, Chan Pin Yin JMPL, Tan HS, Abramoff MD, Twisk JWR, et al. The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy. PLOS ONE. 2020;15:e0231552.","journal-title":"PLOS ONE"},{"key":"2056_CR57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/IAE.0000000000001990","volume":"39","author":"S Vujosevic","year":"2019","unstructured":"Vujosevic S, Muraca A, Alkabes M, Villani E, Cavarzeran F, Rossetti L, et al. Early microvascular and neural changes in patients with type 1 and type 2 diabetes mellitus without clinical signs of diabetic retinopathy. Retina 2019;39:435\u201345.","journal-title":"Retina"},{"key":"2056_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.expneurol.2015.08.007","volume":"273","author":"D Gallina","year":"2015","unstructured":"Gallina D, Zelinka CP, Cebulla CM, Fischer AJ. Activation of glucocorticoid receptors in M\u00fcller glia is protective to retinal neurons and suppresses microglial reactivity. Exp Neurol. 2015;273:114\u201325.","journal-title":"Exp Neurol"},{"key":"2056_CR59","doi-asserted-by":"crossref","first-page":"7589841","DOI":"10.1155\/2019\/7589841","volume":"2019","author":"F Scarinci","year":"2019","unstructured":"Scarinci F, Varano M, Parravano M. Retinal sensitivity loss correlates with deep capillary plexus impairment in diabetic macular ischemia. J Ophthalmol. 2019;2019:7589841.","journal-title":"J Ophthalmol"},{"key":"2056_CR60","doi-asserted-by":"publisher","first-page":"108195","DOI":"10.1016\/j.exer.2020.108195","volume":"199","author":"A Campos","year":"2020","unstructured":"Campos A, Campos EJ, Martins J, Rodrigues FSC, Silva R, Ambr\u00f3sio AF. Inflammatory cells proliferate in the choroid and retina without choroidal thickness change in early Type 1 diabetes. Exp Eye Res. 2020;199:108195.","journal-title":"Exp Eye Res"},{"key":"2056_CR61","doi-asserted-by":"publisher","first-page":"e0207435","DOI":"10.1371\/journal.pone.0207435","volume":"13","author":"C Gupta","year":"2018","unstructured":"Gupta C, Tan R, Mishra C, Khandelwal N, Raman R, Kim R, et al. Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema\u2014A novel OCT based imaging biomarker. PLOS ONE. 2018;13:e0207435.","journal-title":"PLOS ONE"},{"key":"2056_CR62","doi-asserted-by":"publisher","first-page":"e0191977","DOI":"10.1371\/journal.pone.0191977","volume":"13","author":"B Abadia","year":"2018","unstructured":"Abadia B, Su\u00f1en I, Calvo P, Bartol F, Verdes G, Ferreras A. Choroidal thickness measured using swept-source optical coherence tomography is reduced in patients with type 2 diabetes. PLOS ONE. 2018;13:e0191977.","journal-title":"PLOS ONE"},{"key":"2056_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3988\/jcn.2015.11.3.241","volume":"11","author":"YM Huang-Link","year":"2015","unstructured":"Huang-Link YM, Fredrikson M, Link H. Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes. J Clin Neurol. 2015;11:241\u20137.","journal-title":"J Clin Neurol"},{"key":"2056_CR64","doi-asserted-by":"crossref","unstructured":"Birkeldh U, Manouchehrinia A, Hietala MA, Hillert J, Olsson T, Piehl F, et al. The temporal retinal nerve fiber layer thickness is the most important optical coherence tomography estimate in multiple sclerosis. Front Neurol. 2017;1\u20138.","DOI":"10.3389\/fneur.2017.00675"},{"key":"2056_CR65","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16:797\u2013812.","journal-title":"Lancet Neurol"},{"key":"2056_CR66","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s10072-020-04431-4","volume":"41","author":"AM Pietroboni","year":"2020","unstructured":"Pietroboni AM, Carandini T, Dell\u2019Arti L, Bovis F, Colombi A, De Riz MA, et al. Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study. Neurol Sci. 2020;41:3175\u201383.","journal-title":"Neurol Sci"},{"key":"2056_CR67","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1167\/iovs.11-9309","volume":"53","author":"AS Reis","year":"2012","unstructured":"Reis AS, O\u2019Leary N, Yang H, Sharpe GP, Nicolela MT, Burgoyne CF, et al. Influence of clinically invisible, but optical coherence tomography detected, optic disc margin anatomy on neuroretinal rim evaluation. Invest Ophthalmol Vis Sci. 2012;53:1852\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR68","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/WNO.0000000000000768","volume":"39","author":"J Nguyen","year":"2019","unstructured":"Nguyen J, Rothman A, Gonzalez N, Avornu A, Ogbuokiri E, Balcer LJ, et al. Macular ganglion cell and inner plexiform layer thickness is more strongly associated with visual function in multiple sclerosis than bruch membrane opening-minimum rim width or peripapillary retinal nerve fiber layer thicknesses. J Neuroophthalmol. 2019;39:444\u201350.","journal-title":"J Neuroophthalmol"},{"key":"2056_CR69","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","volume":"119","author":"SD Walter","year":"2012","unstructured":"Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012;119:1250\u20137.","journal-title":"Ophthalmology."},{"key":"2056_CR70","doi-asserted-by":"publisher","first-page":"102625","DOI":"10.1016\/j.msard.2020.102625","volume":"47","author":"F Ashtari","year":"2021","unstructured":"Ashtari F, Ataei A, Kafieh R, Khodabandeh Z, Barzegar M, Raei M, et al. Optical coherence tomography in neuromyelitis optica spectrum disorder and multiple sclerosis: a population-based study. Mult Scler Relat Disord. 2021;47:102625.","journal-title":"Mult Scler Relat Disord"},{"key":"2056_CR71","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/brain\/aws098","volume":"135","author":"JM Gelfand","year":"2012","unstructured":"Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012;135:1786\u201393.","journal-title":"Brain"},{"key":"2056_CR72","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","volume":"11","author":"S Saidha","year":"2012","unstructured":"Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012;11:963\u201372.","journal-title":"Lancet Neurol"},{"key":"2056_CR73","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ceo.13327","volume":"46","author":"L Kessel","year":"2018","unstructured":"Kessel L, Hamann S, Wegener M, Tong J, Fraser CL. Microcystic macular oedema in optic neuropathy: case series and literature review. Clin Exp Ophthalmol. 2018;46:1075\u201386.","journal-title":"Clin Exp Ophthalmol"},{"key":"2056_CR74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ophtha.2013.08.045","volume":"121","author":"M Abegg","year":"2014","unstructured":"Abegg M, Dysli M, Wolf S, Kowal J, Dufour P, Zinkernagel M. Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology. 2014;121:142\u20139.","journal-title":"Ophthalmology"},{"key":"2056_CR75","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1093\/brain\/awt014","volume":"136","author":"P Barboni","year":"2013","unstructured":"Barboni P, Carelli V, Savini G, Carbonelli M, La Morgia C, Sadun AA. Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain 2013;136:e239.","journal-title":"Brain"},{"key":"2056_CR76","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1093\/brain\/awt154","volume":"136","author":"BJ Lujan","year":"2013","unstructured":"Lujan BJ, Horton JC. Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface. Brain. 2013;136:e260.","journal-title":"Brain."},{"key":"2056_CR77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1212\/WNL.0000000000000545","volume":"83","author":"AU Brandt","year":"2014","unstructured":"Brandt AU, Oberwahrenbrock T, Kadas EM, Lagr\u00e8ze WA, Paul F. Dynamic formation of macular microcysts independent of vitreous traction changes. Neurology. 2014;83:73.","journal-title":"Neurology"},{"key":"2056_CR78","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1111\/aos.13807","volume":"97","author":"E Garcia-Martin","year":"2019","unstructured":"Garcia-Martin E, Jarauta L, Pablo LE, Bambo MP, Ara JR, Martin J, et al. Changes in peripapillary choroidal thickness in patients with multiple sclerosis. Acta Ophthalmol. 2019;97:e77\u2013e83.","journal-title":"Acta Ophthalmol"},{"key":"2056_CR79","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.jns.2020.117180","volume":"419","author":"A Barreiro-Gonz\u00e1lez","year":"2020","unstructured":"Barreiro-Gonz\u00e1lez A, Sanz MT, Carratal\u00e0-Bosc\u00e0 S, P\u00e9rez-Miralles F, Alcal\u00e1 C, Carreres-Polo J, et al. Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks. J Neurol Sci. 2020;419:117180.","journal-title":"J Neurol Sci"},{"key":"2056_CR80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.msard.2018.03.007","volume":"22","author":"R Alonso","year":"2018","unstructured":"Alonso R, Gonzalez-Moron D, Garcea O. Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: a review. Mult Scler Relat Disord. 2018;22:77\u201382.","journal-title":"Mult Scler Relat Disord"},{"key":"2056_CR81","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","volume":"92","author":"BG Weinshenker","year":"2017","unstructured":"Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;92:663\u201379.","journal-title":"Mayo Clin Proc"},{"key":"2056_CR82","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176:149\u201364.","journal-title":"Clin Exp Immunol"},{"key":"2056_CR83","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awr264","volume":"135","author":"SB Syc","year":"2011","unstructured":"Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford ET, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2011;135:521\u201333.","journal-title":"Brain"},{"key":"2056_CR84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ophtha.2012.07.066","volume":"120","author":"DB Fernandes","year":"2013","unstructured":"Fernandes DB, Raza AS, Nogueira RGF, Wang D, Callegaro D, Hood DC, et al. Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology. 2013;120:387\u201394.","journal-title":"Ophthalmology"},{"key":"2056_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jns.2017.10.028","volume":"383","author":"A Peng","year":"2017","unstructured":"Peng A, Qiu X, Zhang L, Zhu X, He S, Lai W, et al. Evaluation of the retinal nerve fiber layer in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis. J Neurol Sci. 2017;383:108\u201313.","journal-title":"J Neurol Sci"},{"key":"2056_CR86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2017.10.001","volume":"313","author":"T Akaishi","year":"2017","unstructured":"Akaishi T, Kaneko K, Himori N, Takeshita T, Takahashi T, Nakazawa T, et al. Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica. J Neuroimmunol. 2017;313:10\u20135.","journal-title":"J Neuroimmunol"},{"key":"2056_CR87","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jamaneurol.2013.1832","volume":"70","author":"JM Gelfand","year":"2013","unstructured":"Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol. 2013;70:629\u201333.","journal-title":"JAMA Neurol"},{"key":"2056_CR88","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1212\/NXI.0000000000000334","volume":"4","author":"FC Oertel","year":"2017","unstructured":"Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, et al. Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. Neurol Neuroimmunol Neuroinflamm. 2017;4:e334.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2056_CR89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajo.2018.04.026","volume":"192","author":"WR Kwapong","year":"2018","unstructured":"Kwapong WR, Peng C, He Z, Zhuang X, Shen M, Lu F. Altered macular microvasculature in neuromyelitis optica spectrum disorders. Am J Ophthalmol. 2018;192:47\u201355.","journal-title":"Am J Ophthalmol"},{"key":"2056_CR90","doi-asserted-by":"publisher","first-page":"204062231988220","DOI":"10.1177\/2040622319882205","volume":"10","author":"TE Yap","year":"2019","unstructured":"Yap TE, Balendra SI, Almonte MT, Cordeiro MF. Retinal correlates of neurological disorders. Ther Adv Chronic Dis. 2019;10:2040622319882205.","journal-title":"Ther Adv Chronic Dis"},{"key":"2056_CR91","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.msard.2021.102780","volume":"49","author":"GI Lee","year":"2021","unstructured":"Lee GI, Park KA, Oh SY, Min JH, Kim BJ. Differential patterns of parafoveal and peripapillary vessel density in multiple sclerosis and neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2021;49:102780.","journal-title":"Mult Scler Relat Disord"},{"key":"2056_CR92","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1167\/iovs.11-9324","volume":"53","author":"ML Monteiro","year":"2012","unstructured":"Monteiro ML, Fernandes DB, Ap\u00f3stolos-Pereira SL, Callegaro D. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:3959\u201366.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR93","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"JN Ratchford","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73:302\u20138.","journal-title":"Neurology."},{"key":"2056_CR94","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ajo.2020.07.015","volume":"220","author":"S Dulz","year":"2020","unstructured":"Dulz S, Atiskova Y, Wibbeler E, Wildner J, Wagenfeld L, Schwering C, et al. An ophthalmic rating scale to assess ocular involvement in juvenile CLN3 disease. Am J Ophthalmol. 2020;220:64\u201371.","journal-title":"Am J Ophthalmol"},{"key":"2056_CR95","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12311-017-0856-7","volume":"16","author":"F Spina Tensini","year":"2017","unstructured":"Spina Tensini F, Sato MT, Shiokawa N, Ashizawa T, Teive HAG. A comparative optical coherence tomography study of spinocerebellar ataxia types 3 and 10. Cerebellum 2017;16:797\u2013801.","journal-title":"Cerebellum"},{"key":"2056_CR96","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00415-020-09796-2","volume":"267","author":"J Havla","year":"2020","unstructured":"Havla J, Moser M, Sztatecsny C, Lotz-Havla AS, Maier EM, Hizli B, et al. Retinal axonal degeneration in Niemann-Pick type C disease. J Neurol. 2020;267:2070\u201382.","journal-title":"J Neurol"},{"key":"2056_CR97","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ymgme.2009.11.007","volume":"99","author":"M Pineda","year":"2010","unstructured":"Pineda M, Perez-Poyato MS, O\u2019Callaghan M, Vilaseca MA, Pocovi M, Domingo R, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Mol Genet Metab. 2010;99:358\u201366.","journal-title":"Mol Genet Metab"},{"key":"2056_CR98","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia. Neurology. 2006;66:1717.","journal-title":"Neurology."},{"key":"2056_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40673-018-0095-9","volume":"6","author":"K Jensen","year":"2019","unstructured":"Jensen K, Beylergil SB, Shaikh AG. Slow saccades in cerebellar disease. Cerebellum Ataxias. 2019;6:1.","journal-title":"Cerebellum Ataxias"},{"key":"2056_CR100","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1167\/iovs.16-19716","volume":"57","author":"C Blokhuis","year":"2016","unstructured":"Blokhuis C, Demirkaya N, Cohen S, Wit FWNM, Scherpbier HJ, Reiss P, et al. The eye as a window to the brain: neuroretinal thickness is associated with microstructural white matter injury in HIV-infected children. Investigative Ophthalmol Vis Sci. 2016;57:3864\u201371.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"2056_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-58","volume":"14","author":"S Meyer-Moock","year":"2014","unstructured":"Meyer-Moock S, Feng Y-S, Maeurer M, Dippel F-W, Kohlmann T. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 2014;14:58.","journal-title":"BMC Neurol"},{"key":"2056_CR102","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T, \u00d6z G, Paulson HL. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol. 2018;14:590\u2013605.","journal-title":"Nat Rev Neurol"},{"key":"2056_CR103","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s13760-019-01160-0","volume":"119","author":"M Mastrangelo","year":"2019","unstructured":"Mastrangelo M. Clinical approach to neurodegenerative disorders in childhood: an updated overview. Acta neurologica Belgica. 2019;119:511\u201321.","journal-title":"Acta neurologica Belgica"},{"key":"2056_CR104","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","volume":"126","author":"VTT Chan","year":"2019","unstructured":"Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, et al. Spectral-domain OCT measurements in alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology. 2019;126:497\u2013510.","journal-title":"Ophthalmology."},{"key":"2056_CR105","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 2011;54:S204\u201317.","journal-title":"Neuroimage"},{"key":"2056_CR106","doi-asserted-by":"crossref","unstructured":"Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017;2:e93621.","DOI":"10.1172\/jci.insight.93621"},{"key":"2056_CR107","unstructured":"Scharre DW. Preclinical, prodromal, and dementia stages of alzheimer\u2019s disease. Pract Neurol. 2019."},{"key":"2056_CR108","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer\u2019s disease. N. Engl J Med. 1986;315:485\u20137.","journal-title":"N. Engl J Med"},{"key":"2056_CR109","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/WCO.0000000000000645","volume":"32","author":"CY Cheung","year":"2019","unstructured":"Cheung CY, Chan VTT, Mok VC, Chen C, Wong TY. Potential retinal biomarkers for dementia: what is new? Curr Opin Neurol. 2019;32:82\u201391.","journal-title":"Curr Opin Neurol"},{"key":"2056_CR110","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.12006","volume":"16","author":"J Alber","year":"2020","unstructured":"Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, et al. Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: What we know, what we don\u2019t, and how to move forward. Alzheimers Dement. 2020;16:229\u201343.","journal-title":"Alzheimers Dement"},{"key":"2056_CR111","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer\u2019s disease: A systematic review and meta-analysis. Alzheimers Dement (Amst). 2017;6:162\u201370.","journal-title":"Alzheimers Dement (Amst)"},{"key":"2056_CR112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","volume":"45","author":"CY Cheung","year":"2015","unstructured":"Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45:45\u201356.","journal-title":"J Alzheimers Dis"},{"key":"2056_CR113","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WAD.0000000000000176","volume":"31","author":"A Trebbastoni","year":"2017","unstructured":"Trebbastoni A, Marcelli M, Mallone F, D\u2019Antonio F, Imbriano L, Campanelli A, et al. Attenuation of Choroidal Thickness in Patients With Alzheimer Disease: Evidence From an Italian Prospective Study. Alzheimer Dis Assoc Disord. 2017;31:128\u201334.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2056_CR114","doi-asserted-by":"crossref","first-page":"7291257","DOI":"10.1155\/2016\/2898704","volume":"2016","author":"M Bulut","year":"2016","unstructured":"Bulut M, Yaman A, Erol MK, Kurtulu\u015f F, Toslak D, Do\u011fan B, et al. Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer\u2019s Type Dementia. J Ophthalmol. 2016;2016:7291257.","journal-title":"J Ophthalmol"},{"key":"2056_CR115","doi-asserted-by":"crossref","first-page":"e12149","DOI":"10.1002\/dad2.12149","volume":"13","author":"OM Rifai","year":"2021","unstructured":"Rifai OM, McGrory S, Robbins CB, Grewal DS, Liu A, Fekrat S, et al. The application of optical coherence tomography angiography in Alzheimer\u2019s disease: A systematic review. Alzheimers Dement (Amst). 2021;13:e12149.","journal-title":"Alzheimers Dement (Amst)"},{"key":"2056_CR116","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Invest Ophthalmol Vis Sci. 1990;31:2473\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR117","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/08820538.2017.1332233","volume":"33","author":"PP Chhablani","year":"2018","unstructured":"Chhablani PP, Ambiya V, Nair AG, Bondalapati S, Chhablani J. Retinal Findings on OCT in Systemic Conditions. Semin Ophthalmol. 2018;33:525\u201346.","journal-title":"Semin Ophthalmol"},{"key":"2056_CR118","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. \u03b1-synuclein in the inner retina in parkinson disease. Ann Neurol. 2014;75:964\u20136.","journal-title":"Ann Neurol"},{"key":"2056_CR119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","volume":"64","author":"A Chrysou","year":"2019","unstructured":"Chrysou A, Jansonius NM, van Laar T. Retinal layers in Parkinson\u2019s disease: A meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord. 2019;64:40\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"2056_CR120","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s10072-020-04266-z","volume":"41","author":"J Huang","year":"2020","unstructured":"Huang J, Wang Q, Li K, Zhang Q, Xu G, Liu J, et al. Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson\u2019s disease in clinical middle stages. Neurol Sci 2020;41:1909\u201312.","journal-title":"Neurol Sci"},{"key":"2056_CR121","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol. 2002;133:135\u20137.","journal-title":"Am J Ophthalmol"},{"key":"2056_CR122","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1468-1331.2012.03701.x","volume":"20","author":"C La Morgia","year":"2013","unstructured":"La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol. 2013;20:198\u2013201.","journal-title":"Eur J Neurol"},{"key":"2056_CR123","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/08820538.2017.1307423","volume":"33","author":"MM Moschos","year":"2018","unstructured":"Moschos MM, Chatziralli IP. Evaluation of Choroidal and Retinal Thickness Changes in Parkinson\u2019s Disease Using Spectral Domain Optical Coherence Tomography. Semin Ophthalmol. 2018;33:494\u20137.","journal-title":"Semin Ophthalmol"},{"key":"2056_CR124","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1167\/iovs.17-23230","volume":"59","author":"WR Kwapong","year":"2018","unstructured":"Kwapong WR, Ye H, Peng C, Zhuang X, Wang J, Shen M, et al. Retinal Microvascular Impairment in the Early Stages of Parkinson\u2019s Disease. Invest Ophthalmol Vis Sci. 2018;59:4115\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2056_CR125","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27728","volume":"34","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena A, Del Pino R, Reyero P, Gald\u00f3s M, Arana B, Lucas-Jim\u00e9nez O, et al. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases. Mov Disord. 2019;34:1315\u201324.","journal-title":"Mov Disord"},{"key":"2056_CR126","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00415-019-09654-w","volume":"268","author":"A Cerver\u00f3","year":"2021","unstructured":"Cerver\u00f3 A, Casado A, Riancho J. Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window. J Neurol. 2021;268:2083\u20139.","journal-title":"J Neurol"},{"key":"2056_CR127","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","volume":"262","author":"HM Kersten","year":"2015","unstructured":"Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH. Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression. J Neurol. 2015;262:2457\u201365.","journal-title":"J Neurol"},{"key":"2056_CR128","doi-asserted-by":"crossref","unstructured":"Nouri MN, Yeh EA. Neuroinflammatory and demyelinating disorders of childhood. Clin Child Neurol. 2020:651\u201377.","DOI":"10.1007\/978-3-319-43153-6_20"},{"key":"2056_CR129","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ncl.2021.04.004","volume":"39","author":"N Malani Shukla","year":"2021","unstructured":"Malani Shukla N, Lotze TE, Muscal E. Inflammatory diseases of the central nervous system. Neurol Clin. 2021;39:811\u201328.","journal-title":"Neurol Clin"},{"key":"2056_CR130","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/rheumatology\/ket398","volume":"53","author":"M Twilt","year":"2014","unstructured":"Twilt M, Benseler SM. Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy. Rheumatol. 2014;53:1359\u201368.","journal-title":"Rheumatol"},{"key":"2056_CR131","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1352458517690822","volume":"23","author":"LJ Balcer","year":"2017","unstructured":"Balcer LJ, Raynowska J, Nolan R, Galetta SL, Kapoor R, Benedict R, et al. Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. Mult Scler. 2017;23:734\u201347.","journal-title":"Mult Scler"}],"updated-by":[{"DOI":"10.1038\/s41433-022-02083-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02056-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:09:27Z","timestamp":1744182567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02056-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2056"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02056-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-022-02083-6","URL":"https:\/\/doi.org\/10.1038\/s41433-022-02083-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SV: Abbvie-Allergan, Apellis, Bayer, Novartis, Roche SPA: Advisory Board participation MMP: none MEH: This work was supported by the National Institutes of Health EY014800 and an Unrestricted Grant from Research to Prevent Blindness, Inc., New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah; and the National Institutes of Health R01EY015130 and R01EY017011 to MEH. LO\u2019T: Bayer and Novartis: Advisory Board participation. AN: none. Celeste Limoli: none. EV: Allergan: Consultant\/Advisor, Lecture fees, Grant support (AAO Financial Disclosure and First-slide Policy 2021); FB Vision and Santen: Consultant\/Advisor, Lecture fees; Bruschettini, Oftagest, Sooft, Thea and Visufarma: Lecture fees; Alfa intes, OffHealth, Servimed and Shire: Grant support (AAO Financial Disclosure and First-slide Policy 2021). PN: none.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}